Sanofi said it entered into talks with Clayton Dubilier & Rice to offload a controlling stake in its consumer-health division, leaning toward a partial sale to a private-equity firm rather than a ...

Biohaven has surged driven by promising data from its troriluzole trials for spinocerebellar ataxia and ongoing OCD studies.

Sanofi is nearing the sale of its consumer health business to Clayton Dubilier & Rice, a year after Chief Executive Officer ...

Sanofi is in talks to sell a 50% controlling stake in its consumer health unit to CD&R. It is set to be one of the biggest deals this year, following similar moves by big pharma peers GSK Plc, ...

Sanofi said it entered into talks with Clayton Dubilier & Rice to offload a controlling stake in its consumer-health division ...

The French pharmaceutical giant said it’s in negotiations to sell a controlling stake of Opella to the private equity firm CD ...

With reports swirling about potential interest in Sanofi’s consumer health business, the French pharma has confirmed that a ...

The proposed offer from Clayton, Dubilier & Rice (CD&R) would mean the sale of a 50% stake in Opella, which makes ...

There’s about 270 different viruses that can infect humans, and in the fall and winter we're inside more where they can ...

The announcement confirms an earlier Reuters report that it was closing in on a sale estimated at around $16.41bln ...

NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2024 of $0.21 per Class A ...

Macron, a former investment banker dubbed the "Mozart of finance," blew a hole in the country's public finances with a surge in pandemic-related spending; a military buildup and energy subsidies to ...